Gil M. Labrucherie

2013

In 2013, Gil M. Labrucherie earned a total compensation of $1.5M as Senior Vice President and General Counsel at Nektar Therapeutics, a 6% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$278,000
Option Awards$689,055
Salary$504,195
Other$7,238
Total$1,478,488

Labrucherie received $689.1K in option awards, accounting for 47% of the total pay in 2013.

Labrucherie also received $278K in non-equity incentive plan, $504.2K in salary and $7.2K in other compensation.

Rankings

In 2013, Gil M. Labrucherie's compensation ranked 4,993rd out of 12,286 executives tracked by ExecPay. In other words, Labrucherie earned more than 59.4% of executives.

ClassificationRankingPercentile
All
4,993
out of 12,286
59th
Division
Manufacturing
1,720
out of 4,612
63rd
Major group
Chemicals And Allied Products
494
out of 1,466
66th
Industry group
Drugs
349
out of 1,160
70th
Industry
Pharmaceutical Preparations
278
out of 890
69th
Source: SEC filing on April 29, 2016.

Labrucherie's colleagues

We found four more compensation records of executives who worked with Gil M. Labrucherie at Nektar Therapeutics in 2013.

2013

Howard Robin

Nektar Therapeutics

Chief Executive Officer

2013

John Nicholson

Nektar Therapeutics

Chief Financial Officer

2013

Stephen Doberstein

Nektar Therapeutics

Chief Scientific Officer

2013

Rinko Ghosh

Nektar Therapeutics

Senior Vice President and Chief Business Officer

News

You may also like